|Articles|May 9, 2020
COVID-19: How Orbis International is managing operations
Author(s)Alex Delaney-Gesing
Advertisement
Danny Haddad, MD, chief of program at
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
EyePoint receives second consecutive positive recommendation from DSMC
2
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
3
FLORetina 2025: Industry advances front and center at FLORetina Congress
4
FLORetina Congress celebrates 10 years with joint World Retinopathy of Prematurity meeting
5











































